CytomX Therapeutics, Inc. Shares Issued
CytomX Therapeutics, Inc. (CTMX) had Shares Issued of 170.19 million shares as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-03-16
- 2025-12-31: Common Stock, Shares, Issued 170.19M shares.
- 2024-12-31: Common Stock, Shares, Issued 80.10M shares.
- 2023-12-31: Common Stock, Shares, Issued 67.31M shares.
- 2022-12-31: Common Stock, Shares, Issued 66.23M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2025-12-31 | 170.19M shares 10-K · filed 2026-03-16 |
| 2024-12-31 | 80.10M shares 10-K · filed 2026-03-16 |
| 2023-12-31 | 67.31M shares 10-K · filed 2025-03-06 |
| 2022-12-31 | 66.23M shares 10-K · filed 2024-03-11 |
| 2022-09-30 | 65.95M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 65.76M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 65.40M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 65.39M shares 10-K/A · filed 2023-03-27 |
| 2021-09-30 | 65.25M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 65.16M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 65.00M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 48.25M shares 10-K/A · filed 2023-03-27 |
| 2020-09-30 | 46.22M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 46.19M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 45.92M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 45.52M shares 10-K · filed 2021-02-24 |
| 2019-09-30 | 45.43M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 45.40M shares 10-Q · filed 2019-08-07 |
| 2019-03-31 | 45.16M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 45.08M shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 45.00M shares 10-Q · filed 2018-11-06 |
| 2018-06-30 | 39.01M shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 38.90M shares 10-Q · filed 2018-05-09 |
| 2017-12-31 | 38.48M shares 10-K · filed 2019-02-27 |
| 2017-09-30 | 37.10M shares 10-Q · filed 2017-11-07 |
| 2017-06-30 | 36.84M shares 10-Q · filed 2017-08-07 |
| 2017-03-31 | 36.72M shares 10-Q · filed 2017-05-05 |
| 2016-12-31 | 36.49M shares 10-K · filed 2018-03-07 |
| 2016-09-30 | 36.39M shares 10-Q · filed 2016-11-03 |
| 2016-06-30 | 36.19M shares 10-Q · filed 2016-08-03 |
| 2016-03-31 | 36.09M shares 10-Q · filed 2016-05-06 |
| 2015-12-31 | 36.03M shares 10-Q · filed 2016-11-03 |
| 2015-12-10 | 36.03M shares 10-K · filed 2017-03-02 |
| 2015-09-30 | 1.09M shares 10-Q · filed 2015-11-23 |
| 2014-12-31 | 996.52K shares 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |